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Summary
Topoisomerases are essential ubiquitous enzymes,
falling into two distinct classes. A number of eubac-
teria including 
 
Escherichia coli
 
, typically contain four
topoisomerases, two type I topoisomerases and two
type II topoisomerases viz. DNA gyrase and topoi-
somerase IV. In contrast several other bacterial
genomes including mycobacteria, encode for one
type I topoisomerase and a DNA gyrase. Here we
describe a new type II topoisomerase from 
 
Mycobac-
terium smegmatis
 
 which is different from DNA gyrase
or topoisomerase IV in its characteristics and origin.
The topoisomerase is distinct with respect to domain
organization, properties and drug sensitivity. The
enzyme catalyses relaxation of negatively super-
coiled DNA in an ATP-dependent manner and also
introduces positive supercoils to both relaxed and
negatively supercoiled substrates. The genes for this
additional topoisomerase are not found in other
sequenced mycobacterial genomes and may repre-
sent a distant lineage.
Introduction
 
Topoisomerases are the ubiquitous enzymes responsible
for maintaining the topological state of cellular DNA. The
enzymes perform various reactions on DNA including DNA
relaxation, supercoiling, decatenation and unknotting and
thus are involved in essential cellular processes including
transcription, replication, chromosome condensation and
segregation (Wang, 1991; Bates and Maxwell, 1993;
Champoux, 2001). DNA topoisomerases fall into two gen-
eral classes, type I and type II, which are distinguished by
their ability to cleave one or both strands of DNA duplex,
respectively, during a typical topoisomerase reaction
involving DNA breakage, strand passage and religation.
In 
 
Escherichia coli
 
 two type I – topoisomerase I and topoi-
somerase III and two type II topoisomerases – DNA gyrase
and topoisomerase IV have been characterized. Topoi-
somerase I catalyses relaxation of negatively supercoiled
DNA whereas DNA gyrase introduces negative supercoils
into DNA and both the enzymes act as principal swivels
during transcription (Champoux, 2001; Espeli and
Marians, 2004). Topoisomerase IV and topoisomerase III
possess DNA relaxation and decatenation activity (Peng
and Marians, 1993; Nurse 
 
et al
 
., 2003). Between the two
enzymes, topoisomerase IV is the major decatenase in
the cell and is essential for chromosome segregation in
 
E. coli
 
 (Kato 
 
et al
 
., 1990; Levine 
 
et al
 
., 1998). Thus, each
one of the topoisomerases has distinct roles in 
 
E. coli
 
 and
mutation in any of the topoisomerase leads to a compro-
mised growth phenotype (Menzel and Gellert, 1983; Kato
 
et al
 
., 1990; Schofield 
 
et al
 
., 1992; Wang 
 
et al
 
., 2002).
Many eubacteria do not encode for all the four topoi-
somerases described above. Organisms including 
 
Myco-
bacterium tuberculosis
 
 possess only one topoisomerase
each of type I and II classes, i.e. topoisomerase I and DNA
gyrase respectively (Cole 
 
et al
 
., 1998). Such an organiza-
tion, thus, appears to represent the minimal topoi-
somerase requirement for a bacterial cell, to tackle all the
cellular topological requirements. Although most mem-
bers of the genus mycobacteria have the same minimal
topoisomerase content (Philipp 
 
et al
 
., 1996; Cole 
 
et al
 
.,
2001; Camus 
 
et al
 
., 2002; Fleischmann 
 
et al
 
., 2002; Gar-
nier 
 
et al
 
., 2003), analysis of 
 
Mycobacterium smegmatis
 
genome revealed that it has additional open reading
frames (ORFs) encoding for another GyrB and a type II
topoisomerase, other than DNA gyrase. In this manuscript
the studies on the additional type II topoisomerase in 
 
M.
smegmatis
 
 are described. Results reveal that the enzyme
is not a typical topoisomerase IV and exhibits properties
which are of a distinct type II topoisomerase hitherto not
described.
 
Results
 
Additional type II topoisomerase in
 
 M. smegmatis
Two ORFs of 698 and 713 amino acids, named TopoN
and TopoM (TIGR locus: MSMEG0448 and MSMEG0447,
respectively), were identified in 
 
M. smegmatis
 
 genome
sequence with a similarity of 37.5% and 37.8% to its GyrB
and GyrA subunits respectively. The similarity scores were
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even lower, 23% and 21%, respectively, when compared
with GyrB and GyrA from other bacteria. Furthermore,
TopoN and TopoM also showed a very low degree of
similarity (24% and 21%, respectively) to ParE and ParC
from various bacteria. In contrast to this observation, the
multiple sequence alignment of type II topoisomerase
sequences of eubacteria show a high degree of homology
(Caron and Wang, 1994). Generally, gyrase and topoi-
somerase IV genes from different species show very high
degree of similarity (50–70%) to the respective genes
from other species of bacteria. Moreover, within a given
species, the genes for DNA gyrase show significant
similarity with their topoisomerase IV alleles (40–55%).
Against this background, a low degree of similarity of
TopoNM with either gyrase subunits or topoisomerase IV
subunits is not a typical feature. In spite of significant
variation in the sequence alignment with other type II
topoisomerases, the two ORFs (TopoN and TopoM)
appeared to retain the conserved catalytic motifs charac-
teristic of typical type II topoisomerases suggesting that
the two genes might encode for the subunits of a type II
topoisomerase, functioning together as in the case of
other enzymes of this class (Fig. 1A).
 
Phylogenetic analysis of TopoNM
 
The two typical type II topoisomerases, DNA gyrase and
topoisomerase IV, belong to type IIA class. They are dis-
tinguished on the basis of their biochemical properties
and distinct intracellular roles (Espeli and Marians, 2004).
To evaluate the origin and evolutionary relationship of
TopoNM with other type IIA topoisomerases, phylogenetic
analysis was carried out by comparing full-length
sequences of TopoN with ParE sequences and TopoM
with ParC and GyrA sequences respectively (Fig. 1B and
C). The evolutionary tree was also constructed by using
the ATPase domain of TopoN, a region well conserved in
type II topoisomerases (Fig. 1D). All the three phyloge-
netic trees showed a very distant relationship of TopoNM
subunits to that of other type IIA topoisomerases, indicat-
ing an early divergence of TopoNM.
 
Characterization of TopoNM
 
The  
 
topoN
 
 and  
 
topoM
 
 were  cloned  and  expressed  in
 
E.  coli.
 
 Purified TopoN and TopoM proteins have the
predicted sizes of 74 and 77 kDa respectively (Fig. 2A).
Individual polypeptides do not exhibit relaxation or super-
coiling activity while the reconstituted enzyme, comprising
of both the subunits (TopoNM), catalysed the relaxation
of negatively supercoiled DNA in presence of ATP
(Fig. 2B). The specific activity of the enzyme was
determined by titration of individual subunits against
each other and found to be 2.25 
 
×
 
 10
 
4
 
 U mg
 
−
 
1
 
 and
6.49 
 
×
 
 10
 
4
 
 U mg
 
−
 
1
 
 for TopoN and TopoM proteins respec-
tively. One unit of TopoNM comprised of 30 nM of TopoN
and 10 nM of TopoM subunits (Fig. 2B). The Negative
supercoiling activity, characteristic of DNA gyrase, was not
observed in spite of highest similarity to DNA gyrase
(37%) of 
 
M. smegmatis
 
 (not shown). The DNA relaxation
activity of the enzyme is not stimulated by potassium
glutamate in contrast to that of 
 
M. smegmatis
 
 DNA gyrase
(Chatterji 
 
et al.,
 
 2001). The relaxation activity was
observed only in presence of ATP/dATP and the enzyme
was inactive in presence of any other NTP/dNTPs or a
non-hydrolysable analogue of ATP (Fig. 2C). Activity of
TopoNM was magnesium-dependent (Fig. 2D) and was
inhibited above 150 mM NaCl (Fig. 2E). Furthermore, gel
filtration analysis was carried out to investigate the oligo-
meric status of the enzyme. TopoNM activity was recon-
stituted by incubating TopoN and TopoM in a molar ratio
of 3:1 as determined in Fig. 2B. The TopoN, TopoM and
TopoNM elution profiles were analysed in a Superdex S-
200 molecular sieving column. The protein peaks corre-
sponding to TopoN, TopoM and TopoNM were observed
at 16.5 ml, 15.2 ml and 13.7 ml corresponding to the
molecular masses of 80 kDa, 145 kDa and 282 kDa
respectively. From these data the Stokes radii of TopoN,
TopoM and TopoNM were calculated to be 40.2 Å, 51 Å
and 63.4 Å respectively (Fig. S1). These results indicate
that TopoNM is a heterotetramer in solution like other
eubacterial type II topoisomerases. These data also show
TopoN to be a monomer by itself while TopoM is a dimer
in solution (Fig. S1)
Results presented above suggest that TopoNM is a type
II topoisomerase. Another hallmark feature of type II
enzymes is the generation of transient double strand
breaks in DNA before strand passage and religation
steps. Double strand cleavage is visualized by trapping
the enzyme-DNA covalent intermediate using quinolone
class of compounds (Heddle 
 
et al
 
., 2001). Supercoiled
pUC18 DNA was incubated with the enzyme and ciprof-
loxacin and the reactions were arrested by the addition of
SDS followed by proteinase K digestion. Formation of
linear DNA by TopoNM in these reactions confirmed that
the enzyme is a type II topoisomerase (Fig. 2F, lane 3–
8). Substitution of calcium in place of magnesium in DNA
relaxation assays resulted in the generation of double
strand breaks in DNA (data not shown).
 
Introduction of positive supercoils by TopoNM
 
When relaxation assays were carried out using 0.5–3.0
units of TopoNM, few additional topoisomers appeared at
enzyme units higher than 1.5 (Fig. 3A lane 4–7). TopoNM
also introduced additional topoisomers into the relaxed
DNA substrate (Fig. 3B lane 3–7). To determine the nature
of these topoisomers, the products of the relaxation
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assays were resolved both in presence and absence of
ethidium bromide (EtBr) (Fig. 4). At 0.25 and 0.5 enzyme
units, migration of topoisomers was retarded in presence
of EtBr indicating negative superhelicity of DNA (compare
lanes 2 or 3 of Fig. 4A with 4B). In contrast, the topoiso-
mers formed at 1.5 and 1.75 enzyme units migrated faster
in the presence of EtBr indicating positive superhelicity of
the DNA (compare lane 7 or 8 of Fig. 4A and B). For
further confirmation, assays were carried out at three dif-
ferent enzyme concentrations (0.5 U, 1.5 U and 2.5 U)
and the products were resolved by two-dimensional
agarose gel electrophoresis (Fig. 5A). At 0.5 units of
 
Fig. 1.
 
Phylogenetic analysis of TopoNM.
A. Domain organization of type II topoisomerases. Comparison of various domains present in TopoN of 
 
M. smegmatis
 
 with other eubacterial ParE 
and GyrB. Functional domains identified by pfam are indicated. Two conserved domains of type II enzymes namely, Toprim and DNA gyraseB 
domain could not be identified in TopoN. In TopoM subunit, both topoisoIV and gyrA_C, the domains present in eubacterial ParC and GyrA, were 
identified.
B. Phylogenetic tree of TopoN. Phylogenetic tree deduced from amino acid sequences of TopoN of 
 
M. smegmatis
 
 and ParE from other eubacteria.
C. Phylogenetic comparison of TopoM with GyrA and ParC. Phylogenetic tree deduced from amino acid sequences of TopoM of 
 
M. smegmatis
 
 
and GyrA and ParC from other eubacteria.
D. Phylogenetic tree deduced from amino acid sequences of ATPase domain of TopoN and other type II topoisomerases. The species names 
are listed according to the swiss-prot code. Sequence alignments were produced by CLASTALW. Phylogenetic trees were generated with 
 
MEGA
 
2 
using the neighbour-joining algorithm.
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Fig. 1.
 
cont.
 
enzyme, when DNA relaxation by TopoNM is not com-
plete, a left-hand arc is formed, characteristic of negative
supercoils in a two-dimensional gels (Fig. 5B, lane 2). At
2.5 units of TopoNM, topoisomers showed a mobility of
right-hand diagonal and thus were positively supercoiled
(Fig. 5B, lane 4). Assays carried out in parallel, with
different amounts of topoisomerase I and DNA gyrase of
 
M. smegmatis
 
 showed the respective DNA relaxation or
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supercoiling activity; topoisomers with the positive super-
coils were not observed (Fig. 5C and D).
The introduction of positive supercoils by TopoNM could
be either due to enzymatic activity itself or wrapping of the
DNA by the protein. The DNA wrapping mediated positive
supercoiling by the enzyme was examined in a reaction
where 
 
M. smegmatis
 
 topoisomerase I was used to relax
the negatively supercoiled DNA in presence of TopoNM.
 
Fig. 2.
 
Purification of TopoNM and activity assays.
A. Purified fractions of TopoN and TopoM subunits after respective monoQ column chromatography.
B. Reconstitution of enzyme activity. Activity of TopoNM was determined by titration of TopoM with TopoM and vice versa. Lane 1: pUC18 DNA 
substrate. Lane 2: DNA with TopoM. Lanes 3–6: Titration of TopoM with TopoN. Lane 7: DNA with TopoN. Lanes 8–11: Titration of TopoN with 
TopoM.
C. Activity of TopoNM in presence of various energy cofactors.
D and E. Effect of magnesium (D) and ionic strength (E) on TopoNM activity.
F. TopoNM generates double-stranded breaks in DNA in presence of ciprofloxacin. Lane 1: pUC18 DNA substrate. Lane 2. DNA with 20 units of 
TopoNM, Lanes 3–8: DNA with TopoNM and 0.1, 0.2, 0.5, 1.0, 1.5 and 2.0 mg ml
 
−
 
1
 
 of ciprofloxacin. Position of linear DNA is indicated by 
arrowhead. S represents negatively supercoiled DNA. R represents relaxed DNA.
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If the compensatory negative supercoils are generated
as a result of positive supercoils induced by TopoNM-
mediated wrapping of DNA, these would be relaxed by
topoisomerase I in absence of ATP which will result in
change in DNA topology (net positive supercoils) after the
removal of proteins. Absence of any topological changes
in the DNA in such an experiment suggests that the
enzyme is catalytically proficient in introducing positive
supercoils into DNA (Fig. S2).
 
Relaxation of positively supercoiled DNA
 
Furthermore, the activity of TopoNM on positively super-
coiled DNA was determined. The positively supercoiled
substrate was generated by the addition of EtBr to relaxed
pUC18 DNA and was then incubated with increasing con-
centrations of TopoNM. The EtBr was removed from the
assays by butanol extraction and the reaction products
were analysed by agarose gel electrophoresis. Increase
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in the mobility of DNA in presence of TopoNM and ATP
indicates that the enzyme catalyses relaxation of posi-
tively supercoiled DNA (Fig. 6). The relaxation of posi-
tively supercoiled DNA thus formed is ATP-dependent.
ATP-independent relaxation of positive supercoils is not
observed (Fig. S3). This property is in contrast to that of
DNA gyrase, whose DNA relaxation activity is ATP-
independent.
 
Catenation and decatenation activity of TopoNM
 
Next, the ability of TopoNM to catalyse inter molecular
reactions was determined using either one or two plasmid
substrates. PUC18 DNA and pBR322 DNA were incu-
bated together with TopoNM. A decrease in the mobility
of DNA indicated that the enzyme catalyses inter molec-
ular strand passage reactions leading to the formation of
catenated DNA (Fig. 7A). Earlier, we have shown 
 
M.
smegmatis
 
 DNA gyrase is a potent decatenase when
compared with 
 
E. coli
 
 DNA gyrase (Manjunatha 
 
et al
 
.,
2002). The decatenation activity of TopoNM was deter-
mined using the kinetoplast DNA network as substrate.
The unlinking of the plasmid DNA from an interlinked DNA
network was monitored by agarose gel electrophoresis.
Data presented in Fig. 7B show that TopoNM carries out
decatenation of the interlinked molecules. The efficiency
of decatenation by TopoNM was comparable to 
 
M. smeg-
matis
 
 DNA gyrase.
 
Effect of type II topoisomerase inhibitors on TopoNM
 
Type II topoisomerases from eubacteria are targets for
many classes of antibacterials (Maxwell, 1993; Barnard
and Maxwell, 2001; Chatterji 
 
et al
 
., 2001). Among them,
quinolones and coumarins are the well studied potent
inhibitors, which target the two different subunits of these
enzymes (Gormley 
 
et al
 
., 1996; Wentzell and Maxwell,
2000). Quinolone class of drugs inhibit the enzyme activ-
ity by stabilizing the DNA-enzyme covalent complex. Inhi-
bition of 50% activity (IC
 
50
 
) for 
 
M. smegmatis
 
 DNA gyrase
is attained at 3.2 
 
µ
 
g ml
 
−
 
1
 
 concentration of ciprofloxacin
(Guillemin 
 
et al
 
., 1999; Chatterji 
 
et al
 
., 2001, U.H. Manju-
natha, D.R. Radha and V. Nagaraja, unpublished). How-
ever, the inhibition of TopoNM activity was observed only
at very high concentrations viz. IC
 
50
 
 value of 125 
 
µ
 
g ml
 
−
 
1
 
(Fig. 8A). Such high level of drug sensitivity is normally
associated with quinolone resistant DNA gyrase having
mutations in the quinolone resistance determining region
(QRDR) (see 
 
Discussion
 
). Coumarin class of drugs pre-
vent binding of ATP to the enzyme and are competitive
inhibitors of enzyme activity (Lewis 
 
et al
 
., 1996; Maxwell,
1997). Novobiocin inhibits TopoNM activity with an IC
 
50
 
value of 75 
 
µ
 
g ml
 
−
 
1
 
 (Fig. 8B), which is 150-fold higher
than required for the inhibition of mycobacterial DNA
gyrase (Chatterji 
 
et al
 
., 2001). The divergence of TopoN
sequence from a typical GyrB sequence with respect to
ATP and coumarin binding appears to be the primary
reason for the observed resistance of the enzyme to cou-
marins (see 
 
Discussion
 
).
 
Discussion
 
The functional characterization of the four topoisomerases
in 
 
E. coli
 
 provided a general framework on how these
enzymes function and share their intracellular work load
to solve topological problems in prokaryotes (Wang, 1991;
Luttinger, 1995; Espeli 
 
et al
 
., 2003a; Espeli and Marians,
2004). Previous studies established a role for topoi-
somerase I in removal of negative supercoils behind tran-
scription bubble, whereas gyrase was shown to exert its
effect ahead of these machineries in removing positive
supercoils (Liu and Wang, 1987; Champoux, 2001). It was
also established that topoisomerase IV carries out relax-
ation of negatively and positively supercoiled DNA while
DNA gyrase takes care of negative supercoiling. In addi-
tion, the division of labour between DNA gyrase and
topoisomerase IV was unambiguously demarcated in
accordance with their respective activities, which estab-
lished topoisomerase IV as the major decatenase in the
 
Fig. 3.
 
Supercoiling and relaxation activity of TopoNM.
A. TopoNM relaxes negatively supercoiled DNA in the presence of 
ATP. Relaxation assays were carried out using 500 ng of negatively 
supercoiled DNA (S) and increasing concentrations of TopoNM. Lane 
1: pUC18 DNA substrate. Lanes 2–7: DNA with 0.5, 1.0, 1.5, 2.0, 2.5 
and 3.0 units of TopoNM. Note the appearance of additional topoiso-
mers at higher enzyme units (lanes 5–7).
B. TopoNM also introduces supercoils in relaxed DNA. Supercoiling 
assays were carried out using 500 ng of relaxed pUC18 DNA (R) and 
increasing concentrations of TopoNM. Lane 1: relaxed pUC18 DNA. 
Lanes 2–7: relaxed DNA with 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 units of 
TopoNM. The additional topoisomers appeared have been indicated.
S R
+ATP
TopoNM
S
1         2         3         4         5        6         7
R
TopoNM
R S
+ATP
1         2         3         4         5        6         7
A
B
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cell (Hiasa and Marians, 1996; Espeli 
 
et al
 
., 2003b; Nurse
 
et al
 
., 2003). Furthermore, it was shown that DNA gyrase
is the primary target for quinolone class of drugs in Gram-
negative organisms, while in Gram-positives, topoi-
somerase IV is the primary target (Higgins 
 
et al
 
., 2003).
In contrast to the latter typical type II enzymes, TopoNM
exhibits positive supercoiling activity, not seen so far with
other eubacterial topoisomerases. Among all topoi-
somerases only reverse gyrases, found in hyperthermo-
philic eubacteria and archaea which belong to type IA
class are shown to introduce positive supercoils into the
genome (Forterre 
 
et al
 
., 2000; Forterre, 2002). The phy-
logenetic divergence of TopoNM from DNA gyrase or
topoisomerase IV clusters also argues against its group-
ing with topoisomerase IV or DNA gyrase. In contrast to
these typical enzymes, TopoNM is highly resistant to qui-
nolone and coumarin class of compounds; conversion of
supercoiled pUC18 DNA into relaxed covalently closed
circular form is inhibited at drug concentrations that are
physiologically irrelevant. Mutations in the QRDR region
in the N-terminal region of GyrA are the primary cause for
reduced susceptibility of DNA gyrase towards fluoroqui-
nolones. Accordingly a single or double mutations in the
QRDR are associated with 16- or 32-fold increase in MICs
of the drug resistant enzyme (Kocagoz 
 
et al
 
., 1996). An
Asp to Gly change at position 94 of M. tuberculosis GyrA
confers ciprofloxacin resistance (Takiff et al., 1994).
TopoM naturally contains Gly at this position. Similarly,
one of the reasons for the observed resistance to novo-
biocin could be because of the significant variation in the
ATPase domain of TopoNM from that of canonical ATP
binding pocket found in other topoisomerases. Based on
the structure of novobiocin complexed with the GyrB N-
terminal domain, sequence alignment and mutation stud-
ies with topoisomerase IV, several residues involved in
binding of novobiocin to GyrB and ParE have been iden-
tified (Lewis et al., 1996; Hardy and Cozzarelli, 2003; Bel-
lon et al., 2004). In an alignment between TopoN, ParE
and GyrB, Tyr109 of GyrB, which is shown to contact
novobiocin, is replaced by Asp in TopoN. Gly64, Ile78 and
Thr165 of E. coli GyrB, when mutated, confer resistance
to novobiocin and these residues are naturally replaced
by Ser, Lys and Asn, respectively, in TopoN. Moreover, the
ATPase domain of TopoN forms an independent branch
and does not fall  into any of the three clusters formed
by GyrB/ParE, topoisomerase II and topoisomerase VI
(Fig. 1C). The TopoNM falls into a group different from
gyrase and topoisomerase IV even when the ATPase
domain of TopoN is not included in the phylogenetic anal-
ysis (not shown). Furthermore, the topoN and topoM
Fig. 4. Positive supercoiling activity of TopoNM.
A. Activity assays were performed using 500 ng of negatively supercoiled pUC18 DNA and increasing concentrations of TopoNM. Reactions were 
resolved on a 1.2% agarose gel in the absence of EtBr.
B. Identical samples (as shown in A) were also resolved on a 1.2% agarose gel in the presence of 50 ng ml−1 EtBr. Lane 1: pUC18 DNA substrate. 
Lanes 2–8: DNA with 0.25, 0.5, 0.75, 1.0, 1.25, 1.5 and 1.75 units of TopoNM.
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Fig. 5. Topological reactions catalysed by topoisomerases from M. smegmatis.
A. Schematic representation of two-dimensional agarose gel electrophoresis showing the migration of positive and negative topoisomers.
B. Reactions with TopoNM. Lane 1: migration of negatively supercoiled pUC18 DNA substrate. Lane 2: partial relaxation of negatively supercoiled 
DNA at 0.5 units of TopoNM. Lane 3: transition from negatively supercoiled to positively supercoiled DNA at 1.5 units of TopoNM. Lane 4: formation 
of positively supercoiled DNA at 2.5 units of TopoNM.
C. Reactions with topoisomerase I. Lane 1: negatively supercoiled pUC18 DNA substrate. Lane 2: partial relaxation of negatively supercoiled 
DNA at 3 units of topoisomerase I. Lane 3: Complete relaxation of the DNA at 6 units of topoisomerase I. Lane 4: no introduction of positive 
supercoils in DNA at 15 units topoisomerase I.
D. Reaction with DNA gyrase. Lane 1: relaxed pUC18 DNA as substrate. Lane 2: introduction of negative supercoils at 0.5 units of DNA gyrase. 
Lane 3: complete negative supercoiling of DNA at 1.5 units of DNA gyrase.
2nd dimension (+ EtBr)
DNA gyraseTopoisomerase I
1st dimension
(-EtBr)
–/+ +–Lk
TopoNM
A B
C D
1       2          3               4  1       2          3    4  
1       2    3  1       2          3    4  
Fig. 6. Activity of TopoNM on positively supercoiled DNA substrate. Relaxed DNA was incubated with 0.2 µg of EtBr to covert it into positively 
supercoiled DNA and incubated with increasing concentrations of TopoNM. EtBr was removed from the reaction products by butanol extraction, 
from lanes 2–8, before resolving on 1.2% agarose gel. Lane 1: relaxed DNA. Lane 2: relaxed DNA with EtBr (positively supercoiled DNA) followed 
by butanol extraction. Lanes 3–8: relaxed DNA with EtBr and 1.0, 1.5, 2.0, 2.5, 3.0 and 3.5 units of TopoNM followed by butanol extraction. The 
arrows between the DNA bands indicate increase in negative supercoiling of DNA with increasing enzyme concentrations. Reaction scheme is 
shown on right side of the figure.
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could not complement E. coli gyr and par ts strains and
also Salmonella typhimurium parE and parC ts strains
(not shown). All these data, together, indicate early diver-
gence of TopoNM genes from rest of the genes that
encode type II topoisomerases in eubacteria. Elucidation
of a number of topoisomerase II structure have led to a
greater understanding of their architecture, enzyme action
and reaction mechanisms (Corbett and Berger, 2003,
2004). As TopoNM is overexpressed in large amounts in
soluble form, it is amenable for structural studies which
would provide clues on its function.
With a number of bacterial genomes deciphered, it has
become apparent that many, including M. tuberculosis,
possess only two topoisomerases viz. DNA topoi-
somerase I and DNA gyrase. In such a scenario, DNA
gyrase would relax the positive torsional stress generated
during transcription and replication and also catalyse the
decatenation of replicated DNA, taking over the role of
topoisomerase IV. In accordance with this, we have shown
that mycobacterial DNA gyrase catalyses the decatena-
tion of interlinked molecules efficiently (Manjunatha et al.,
2002). Meanwhile, topoisomerase I would remove nega-
tive supercoils arising during various DNA transaction pro-
cesses and prevent excessive negative supercoiling by
DNA gyrase. Identification of an additional type II topoi-
somerase from M. smegmatis with unusual properties
adds a new twist on the diversity and varied topoi-
somerase distribution and their intracellular functions in
bacterial kingdom. None of the other mycobacterial
genomes encode the genes for the new topoisomerase.
DNA Gyrase (units)
K-DNA
TopoNM (units)
+        +       +        +         +
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1        2        3          4        5 
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1        2        3          4        5 
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n
Fig. 7. Catenation and decatenation activity of 
TopoNM.
A. Catenation assays were carried out using 
pUC18 and pBR322 DNA and 1 unit of 
TopoNM. Lane 1, 500 ng of pBR322 DNA. Lane 
2, 500 ng of pUC18 DNA. Lane 3, 500 ng of 
pBR322 DNA with TopoNM. Lane 4, 500 ng of 
pBR322 DNA and 250 ng of pUC18 DNA with 
TopoNM. Lane 5, 500 ng of pBR322 DNA and 
500 ng of pUC18 DNA with TopoNM.
B. Decatenation assays were carried out with 
TopoNM and DNA gyrase. Lane 1, Catenated 
DNA substrate. Lanes 2 and 3, substrate with 
1 and 2 units of DNA gyrase respectively. Lanes 
4 and 5, substrate with 1 and 2 units of TopoNM 
respectively.
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M. smegmatis has the largest genome (6.9 Mb) with 6901
genes in comparison to other sequenced mycobacteria
(Mycobacterium avium 4.83 Mb; Mycobacterium bovis
4.35 Mb; Mycobacterium tuberculosis CDC1551 4.4 Mb;
M. tuberculosis H37Rv 4.4 Mb) with number of genes
ranging from 3920 to 4350. In all these smaller genomes
only topoisomerase I and DNA gyrase manage to accom-
plish all the topological reactions needed for cell function.
Higher organisms with larger genomes have additional
topoisomerases to cope up with cellular requirements.
Thus, there appears to be some correlation relating
genome size and the existence of additional topoi-
somerase within genus mycobacteria. However, compar-
ison with other eubacterial genomes such as E. coli and
many others do not reveal such correlation. The latter
genomes have an average genome size of 4 Mb and
encode full complement of four topoisomerases.
The strong decatenase activity of TopoNM would imply
a role for the enzyme in chromosome segregation either
playing a back up function to gyrase or an up front role.
M. smegmatis has 10 times faster growth rates than M.
tuberculosis and many other mycobacteria and hence
additional relaxation and decatenation activities may
reflect the requirements of important cellular physiology.
The  positive  supercoiling  activity  on  the  other  hand
may contribute in chromosome compaction. The positive
supercoiling activity of reverse gyrases encoded by hyper-
thermophilic organisms have a role in protecting genome
integrity. The DNA chaperone activity of these enzymes
impart resistance to genome against high temperature
and UV irradiation (Kampmann and Stock, 2004; Napoli
et al., 2004). Although the positive supercoiling activity of
TopoNM is not comparable with that of reverse gyrases,
another possible function could be its role in protecting
the genome from a hostile growth environment. The dis-
tinctive nature of the enzyme may also represent yet
unknown roles in other DNA transaction processes.
Experimental procedures
Computational analysis
Mycobacterium smegmatis genome sequence was analy-
sed using WU-BLAST (http://tigrblast.tigr.org/cmr-blast).
Presence of various domains in the proteins were predicted
using pfam algorithm. Proteins annotated as GyrB and ParE
were aligned with TopoN; and those annotated as GyrA and
ParC were aligned with TopoM using CLUSTALW. MEGA ver-
sion 2 was used for phylogenetic analysis. The trees were
constructed using the neighbour-joining method (Kumar
et al., 2001).
Plasmid construction
To construct pRSET-topoN (pJPN-N) and pRSET-topoM
(pJPN-M), the ORFs corresponding to topoN (2094 nucle-
otides) and topoM (2139 nucleotides) were amplified from
M. smegmatis MC2 chromosomal DNA by polymerase chain
reaction (PCR) (5′-CCATCGATAAGATCTCATATGTCTGAT
CCGGGCGTCTACCA-3′ and 5′-GCTCTAGACCTAAGTCAG
Fig. 8. TopoNM susceptibility to topoisomerase inhibitors. Relaxation assays were performed with 500 ng of negatively supercoiled pUC18 DNA 
and 1 unit of TopoNM in the presence (A) ciprofloxacin and (B) novobiocin. % relaxation activity is plotted as a function of drug concentration.
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GTCCAGCGCG-3′ or 5′-CCATCGATAAGATCTCATATGAC
CGCCACCTTGGACGTTCC-3′ and 5′-GCTCTAGACCTAC
TCCGCGGGGGCGGT-3′ respectively). The PCR fragments
were digested with NdeI and XbaI and cloned into unique
NdeI and XbaI sites of pRSET-A (Invitrogen).
Protein expression and purification
BL26(DE3) cells harbouring either pJPN-N or pJPN-M were
grown till 0.6 OD600 and induced with 0.3 mM IPTG for 3 h at
37°C. Cell free protein extracts were prepared in buffer A
(20 mM  Tris-HCl,  pH 8.0,  2 mM  EDTA,  50 mM  KCl,  5 mM
β-mercaptoethanol and 5% glycerol) and centrifuged at
100 000 g for 2 h. After 0–65% ammonium sulphate fraction-
ation of the supernatant, the pellet fraction was dialysed
against buffer B (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 5 mM
β-mercaptoethanol and 5% glycerol). Both TopoN and TopoM
were purified using Hitrap-heparin followed by Hitrap-mono
Q column chromatography with a linear gradient of 0.05–
1.0 M NaCl. The protein samples were resolved on an 8%
glycine-acrylamide SDS-PAGE (Laemmli, 1970). Gels were
stained with Coomassie blue R-250 (0.1% in 10% acetic acid,
10% methanol) and then destained with 10% methanol, 10%
acetic acid. The active protein fractions were dialysed against
buffer C (50 mM Tris-HCl, pH 8.0, 0.2 mM EDTA, 1 mM β-
mercaptoethanol and 10% glycerol) and stored at −70°C. Unit
activity for TopoNM was defined as the amount of enzyme
required for complete relaxation of 500 ng of negatively
supercoiled pUC18 DNA in 30 min at 37°C.
Mycobacterium smegmatis topoisomerase I and DNA
gyrase were purified as described previously (Bhaduri et al.,
1998; Manjunatha et al., 2002).
Relaxation of plasmids
Negatively supercoiled pUC18 plasmid was incubated with
M. smegmatis topoisomerase I in a reaction buffer containing
40 mM Tris-HCl, pH 8.0, 20 mM KCl, 5 mM MgCl2 at 37°C for
45 min. Reactions were heat inactivated at 65°C for 30 min.
DNA was recovered by ethanol precipitation.
Topoisomerase assays
Relaxation and supercoiling assays with TopoNM and DNA
gyrase were carried out in buffer containing 40 mM Tris-HCl,
pH 7.5, 6 mM MgCl2, 10 mM DTT, 1 mM spermidine-HCl,
20 mM KCl, 1 mM ATP, 50 µg ml−1 bovine serum albumin and
500 ng of negatively supercoiled or relaxed pUC18 DNA at
37°C for 30 min. Reactions were terminated by the addition
of 50 mM EDTA, 1% SDS and 50 µg ml−1 proteinase K (Peng
and Marians, 1993; Manjunatha et al., 2002). Relaxation
assays with topoisomerase I were carried out in a buffer
containing 40 mM Tris-HCl, pH 8.0, 20 mM NaCl, 5 mM
MgCl2 and 500 ng of negatively supercoiled pUC18 DNA at
37°C for 30 min as described previously (Bhaduri et al.,
1998).
Catenation assays were carried out in buffer containing
40 mM Tris-HCI, pH 7.5, 2 mM MgCl2, 10 mM DTT, 100 mM
potassium glutamate, 1.4 mM ATP, 50 µg ml−1 bovine serum
albumin, 15% PEG, 500 ng of supercoiled pUC18 DNA (or
pUC18 and pBR322 DNA together), were incubated with 2.5
units of TopoNM at 37°C for 30 min.
Decatenation assays were carried out using 500 ng of
kinetoplast DNA (K-DNA) in buffer containing 40 mM Tris-
HCI, pH 7.5, 2 mM MgCl2, 10 mM DTT, 100 mM potassium
glutamate, 40 µM ATP, 50 µg ml−1 bovine serum albumin and
500 ng of catenated DNA at 37°C for 30 min. The reaction
products were resolved on a 1.2% agarose gel and visualized
with EtBr staining.
One dimension gel electrophoresis
DNA topoisomers were resolved in 1.2% agarose gel in the
absence of EtBr in TAE buffer (unless indicated). To differen-
tiate the positively supercoiled topoisomers with negatively
supercoiled topoisomers in one dimension, gels were
resolved in presence of 50 ng ml−1 EtBr. Gel electrophoresis
was carried out at 5 v cm−1 for 16 h.
Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis was performed in TBE
buffer, at 5 v cm−1 for 16–17 h, in first dimension and 2 v cm−1
for 15 h in second dimension. Relaxed to supercoiled plas-
mids were fractionated on a 1.2% agarose gel in the absence
of EtBr and negative and positively supercoiled plasmids
were fractionated in presence of 30 ng ml−1 EtBr during the
second dimension. Negatively supercoiled pUC18 DNA was
used as substrate for topoisomerase I and TopoNM. Relaxed
pUC18 DNA was used as substrate for DNA gyrase. Gels
were stained with EtBr (1 mg ml−1). Stained gels were photo-
graphed under UV light using the Bio-Rad gel documentation
system.
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Supplementary material
The following supplementary material is available for this
article online:
Fig. S1. TopoN and TopoM were dialysed against buffer C
lacking glycerol. A total of 150 µg of TopoN, 50 µg of TopoM
and TopoNM (reconstituted with same amounts of TopoN and
TopoM) were loaded onto a 25 ml Superdex S-200 column
equilibrated with buffer C (lacking glycerol) at a flow rate of
0.5 ml min−1.
A. Absorbance at 214 nm ploted against elution volume.
B. Determination of Stokes radius of proteins eluting in dif-
ferent elution volumes following calibration of the column
using thyroglobulin, catalase, albumin, ovalbumin, chemot-
rypsinogen A as standards.
Fig. S2. Negatively supercoiled pUC18 DNA (0.175 pmol)
was incubated with 0.1–1.6 pmol of TopoNM in the relaxation
assay buffer lacking ATP (40 mM Tris-HCl, pH 7.5, 6 mM
MgCl2, 10 mM DTT, 1 mM spermidine-HCl, 20 mM KCl and
50 µg ml−1 bovine serum albumin). After 10 min 0.1 pmol of
M. smegmatis topoisomerase I was added and the reactions
were incubated for 2 h at 37°C. The reactions were termi-
nated by the addition of 0.1% SDS and were treated with
proteinase K to a final concentration of 50 µg ml−1 for 30 min
at 37°C. The reaction products were resolved on a 0.1%
agarose gel in the absence of EtBr and the topoisomers were
visualized after staining with EtBr.
Fig. S3. Relaxed pUC18 DNA (500 ng) was incubated with
2 µg ml−1 of EtBr in the relaxation assay buffer of TopoNM
lacking ATP to generate positively supercoiled DNA. The
positively supercoiled DNA was incubated with TopoNM
either in presence or absence of 1 mM ATP at 37°C for
30 min. After the reaction, EtBr was removed by butanol
extraction and the products were resolved by agarose gel
electrophoresis. Lane 1: relaxed pUC18 DNA; lane 2: posi-
tively supercoiled DNA after butanol extraction. Lanes 3 and
4: positively supercoiled DNA with 1 and 2 units of TopoNM
in the presence of ATP. Lanes 5 and 6: positively supercoiled
DNA with 1 and 2 units of TopoNM in the absence of ATP.
This material is available as part of the online article from
http://www.blackwell-synergy.com
